CCL19 and neoplasm: Other studies have explored the possibility of using oncolytic vaccinia virus to express chemokines such as CCL5 and CCL19 to enhance the therapeutic effect by increasing T cell and dendritic cell infiltration into tumor tissues [31, 32].